Back to search
FDAFDA · Food and drugs·Recall number D-1077-2019

Morphine Sulfate USP Milled, Active Pharmaceutical Ingredient, Rx only, Johnson Matthey Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, NJ 08066-1742

Published April 10, 2019 · Recall initiated: March 5, 2018

Summary

FDA records drug Class II recall D-1077-2019, published April 10, 2019 and initiated March 5, 2018. Recalling firm: Johnson Matthey Inc.; Status: Terminated; Reported quantity: 169.976 kg; Lot: Lot# B1414-160809, Retest Date AUG 2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microbial Contamination of Non-Sterile Products: Bioburden out of specification results for Morphine Sulfate API.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Johnson Matthey Inc.
Distributor
Nationwide in the US
Lot
Lot# B1414-160809, Retest Date AUG 2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Morphine Sulfate USP Milled, Active Pharmaceutical Ingredient, Rx only, Johnson Matthey Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, NJ 08066-1742 recalled?

Yes. FDA published recall D-1077-2019 on April 10, 2019. Reported hazard: Microbial Contamination of Non-Sterile Products: Bioburden out of specification results for Morphine Sulfate API.

What should I do if I have this product?

Voluntary: Firm initiated · Letter